The landscape of dementia prognosis has developed drastically with the appearance of sophisticated biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based tests that may detect Alzheimer's pathology many years ahead of signs or symptoms arise. Even though these technological improvements represent extraordinary development in knowing neurodegenerative ailments, https://aaronq641oxg0.newbigblog.com/profile